Cytokinetics CYTK
NASDAQ CYTK
$72.72 -1.23 (-1.66%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cytokinetics (CYTK) Preferred Shares (2010 - 2013)

Analysis

Cytokinetics (CYTK) Preferred Shares (2010 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Cytokinetics 9.63 Bn 8.46 Bn 25.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 10.00 Mn
Dec 31, 2012 10.00 Mn
Sep 30, 2012 10.00 Mn
Jun 30, 2012 10.00 Mn
Mar 31, 2012 10.00 Mn
Dec 31, 2011 10.00 Mn
Dec 31, 2010 10.00 Mn